Jeffrey A Whitnell's Net Worth

$1.4 Million

Estimate Recalculated Nov 1, 2024 10:58AM EST

Who is Jeffrey A Whitnell

Jeffrey A Whitnell has an estimated net worth of $1.4 Million. This is based on reported shares across multiple companies, which include AKORN INC, and ELITE PHARMACEUTICALS INC /DE/.

SEC CIK

Jeffrey A Whitnell's CIK is 0001126562

Past Insider Trading and Trends

2006 was Jeffrey A Whitnell's most active year for acquiring shares with 2 total transactions. Jeffrey A Whitnell's most active month to acquire stocks was the month of January. 2007 was Jeffrey A Whitnell's most active year for disposing of shares, totalling 7 transactions. Jeffrey A Whitnell's most active month to dispose stocks was the month of October. 2004 saw Jeffrey A Whitnell paying a total of $59,850.00 for 15,000 shares, this is the most they've acquired in one year. In 2007 Jeffrey A Whitnell cashed out on 32,633 shares for a total of $233,878.30, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AKORN INC

Interim CEO/CFO
Updated Apr 23, 2009
Form 4/A
-13.74%
-10.00K
$0.93
-$9.30K
Apr 23, 2009
62.78K
Tax
Apr 20
Form 4
-13.74%
-10.00K
$0.93
-$9.30K
Apr 21, 2009
62.78K
Tax
Apr 20
Form 4
-12.08%
-10.00K
$5.03
-$50.30K
Apr 22, 2008
72.78K
Tax
Apr 20
Form 4
-15.69%
-15.41K
$6.93
-$106.76K
Nov 14, 2007
82.78K
Sale
Nov 12 - Nov 13
Form 4
-14.93%
-17.23K
$7.38
-$127.12K
Apr 24, 2007
98.18K
Tax
Apr 20
Form 4
133.00K
Jan 04, 2007
133.00K
Grant
Jan 01
Form 4
1,732.87%
267.00K
Apr 24, 2006
282.41K
Grant
Apr 20
Form 4
-29.45%
-6.43K
$4.86
-$31.25K
Apr 12, 2006
15.41K
Tax
Mar 31
Form 4
21.84K
May 31, 2005
21.84K
Grant
May 27
Form 4
15.00%
15.00K
$3.99
$59.85K
Nov 24, 2004
115.00K
Grant
Nov 15
Form 3
Aug 25, 2004
Showing 11 results

ELITE PHARMACEUTICALS INC /DE/

Investor
Updated Nov 27, 2023
Form 4
20.75%
547.66K
$0.04
$19.99K
Nov 27, 2023
3.19M
Grant
Nov 22
Form 4
21.08%
459.54K
$0.04
$19.99K
Aug 29, 2022
2.64M
Grant
Aug 28
Form 4
15.69%
295.57K
$0.07
$20.01K
Jul 01, 2021
2.18M
Grant
Jun 30
Form 4
37.79%
516.78K
$0.09
$45.01K
Aug 24, 2020
1.88M
Grant
Aug 20
Form 4
13.38%
161.37K
$0.12
$19.99K
Feb 27, 2018
1.37M
Grant
Feb 26
Form 4
7.94%
88.68K
$0.23
$20.00K
Feb 27, 2017
1.21M
Grant
Feb 23
Form 4
7.87%
81.55K
$0.25
$20.00K
Feb 18, 2016
1.12M
Grant
Feb 16
Form 4
5.98%
58.48K
$0.34
$20.00K
Mar 09, 2015
1.04M
Grant
Mar 05
Form 4
29.06%
220.11K
$0.09
$20.01K
Feb 27, 2014
977.40K
Grant
Feb 25
Form 4
32.26%
184.71K
$0.08
$14.78K
Mar 11, 2013
757.29K
Grant
Mar 07
Form 4
67.94%
231.63K
$0.10
$22.45K
Mar 21, 2012
572.59K
Grant
Mar 20
Form 4
340.95K
$0.04
$13.64K
Mar 16, 2011
340.95K
Purchase
Feb 03
Form 3
Feb 23, 2011
Showing 13 results